245 related articles for article (PubMed ID: 26898195)
21. CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia.
Chen D; Camponeschi A; Wu Q; Gerasimcik N; Li H; Shen X; Tan Y; Sjögren H; Nordlund J; Lönnerholm G; Abrahamsson J; Fogelstrand L; Mårtensson IL
Br J Haematol; 2019 Feb; 184(3):418-423. PubMed ID: 30484860
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of central nervous system relapse of pediatric acute lymphoblastic leukemia: Impact of routine cytological CSF analysis at the time of intrathecal chemotherapy.
Gassas A; Krueger J; Alvi S; Sung L; Hitzler J; Lieberman L
Pediatr Blood Cancer; 2014 Dec; 61(12):2215-7. PubMed ID: 25212396
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.
Sędek Ł; Theunissen P; Sobral da Costa E; van der Sluijs-Gelling A; Mejstrikova E; Gaipa G; Sonsala A; Twardoch M; Oliveira E; Novakova M; Buracchi C; van Dongen JJM; Orfao A; van der Velden VHJ; Szczepański T;
J Immunol Methods; 2019 Dec; 475():112429. PubMed ID: 29530508
[TBL] [Abstract][Full Text] [Related]
25. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
26. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
27. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
Sanchez R; Ayala R; Alonso RA; Martínez MP; Ribera J; García O; Sanchez-Pina J; Mercadal S; Montesinos P; Martino R; Barba P; González-Campos J; Barrios M; Lavilla E; Gil C; Bernal T; Escoda L; Abella E; Amigo ML; Moreno MJ; Bravo P; Guàrdia R; Hernández-Rivas JM; García-Guiñón A; Piernas S; Ribera JM; Martínez-López J
Ann Hematol; 2017 Jul; 96(7):1069-1075. PubMed ID: 28451802
[TBL] [Abstract][Full Text] [Related]
29. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D
Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858
[TBL] [Abstract][Full Text] [Related]
30. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data.
Lenk L; Alsadeq A; Schewe DM
Cancer Metastasis Rev; 2020 Mar; 39(1):173-187. PubMed ID: 31970588
[TBL] [Abstract][Full Text] [Related]
31. High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes.
Fernández-Sevilla LM; Valencia J; Ortiz-Sánchez P; Fraile-Ramos A; Zuluaga P; Jiménez E; Sacedón R; Martínez-Sánchez MV; Jazbec J; Debeljak M; Fedders B; Stanulla M; Schewe D; Cario G; Minguela A; Ramírez M; Varas A; Vicente Á
Blood; 2022 Jun; 139(22):3303-3313. PubMed ID: 35313334
[TBL] [Abstract][Full Text] [Related]
32. Serum adenosine deaminase and arylsulphatase A as an index of early infiltration of central nervous system in acute lymphoblastic leukemia.
Hussein NG; el-Belbessy SF
J Egypt Public Health Assoc; 1998; 73(1-2):97-109. PubMed ID: 17249214
[TBL] [Abstract][Full Text] [Related]
33. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: a study of five cases controlled by genetic methods.
Dworzak MN; Stolz F; Fröschl G; Printz D; Henn T; Fischer S; Fleischer C; Haas OA; Fritsch G; Gadner H; Panzer-Grümayer ER
Exp Hematol; 1999 Apr; 27(4):673-81. PubMed ID: 10210325
[TBL] [Abstract][Full Text] [Related]
34. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
Cario G; Izraeli S; Teichert A; Rhein P; Skokowa J; Möricke A; Zimmermann M; Schrauder A; Karawajew L; Ludwig WD; Welte K; Schünemann HJ; Schlegelberger B; Schrappe M; Stanulla M
J Clin Oncol; 2007 Oct; 25(30):4813-20. PubMed ID: 17947730
[TBL] [Abstract][Full Text] [Related]
35. IL7R is associated with CNS infiltration and relapse in pediatric B-cell precursor acute lymphoblastic leukemia.
Alsadeq A; Lenk L; Vadakumchery A; Cousins A; Vokuhl C; Khadour A; Vogiatzi F; Seyfried F; Meyer LH; Cario G; Hobeika E; Debatin KM; Halsey C; Schrappe M; Schewe DM; Jumaa H
Blood; 2018 Oct; 132(15):1614-1617. PubMed ID: 30154115
[No Abstract] [Full Text] [Related]
36. Flow Cytometric Detection of Malignant Blasts in Cerebrospinal Fluid: A Biomarker of Central Nervous System Involvement in Childhood Acute Lymphoblastic Leukemia.
Thastrup M; Marquart HV; Schmiegelow K
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740938
[TBL] [Abstract][Full Text] [Related]
37. Early detection of central nervous system relapse by polymerase chain reaction in children with B-precursor acute lymphoblastic leukemia.
de Haas V; Vet RJ; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
Ann Hematol; 2002 Jan; 81(1):59-61. PubMed ID: 11807640
[No Abstract] [Full Text] [Related]
38. A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.
Sutton R; Venn NC; Law T; Boer JM; Trahair TN; Ng A; Den Boer ML; Dissanayake A; Giles JE; Dalzell P; Mayoh C; Barbaric D; Revesz T; Alvaro F; Pieters R; Haber M; Norris MD; Schrappe M; Dalla Pozza L; Marshall GM
Br J Haematol; 2018 Feb; 180(4):550-562. PubMed ID: 29194562
[TBL] [Abstract][Full Text] [Related]
39. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia.
Jaime-Pérez JC; Borrego-López MF; Jiménez-Castillo RA; Méndez-Ramírez N; Salazar-Riojas R; Fernández LT; Gómez-Almaguer D
Int J Lab Hematol; 2018 Apr; 40(2):169-174. PubMed ID: 29115725
[TBL] [Abstract][Full Text] [Related]
40. 12p chromosomal aberrations in precursor B childhood acute lymphoblastic leukemia predict an increased risk of relapse in the central nervous system and are associated with typical blast cell morphology.
van der Plas DC; Dekker I; Hagemeijer A; Hooijkaas H; Hählen K
Leukemia; 1994 Dec; 8(12):2041-6. PubMed ID: 7807992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
